SZLS.TO Stock - StageZero Life Sciences Ltd.
Unlock GoAI Insights for SZLS.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $3.80M | $5.07M | $4.15M | $138,704 | $185,874 |
| Gross Profit | $-403,745 | $1.18M | $695,555 | $-960,911 | $-1,079,316 |
| Gross Margin | -10.6% | 23.2% | 16.8% | -692.8% | -580.7% |
| Operating Income | $-7,746,761 | $-8,130,842 | $-3,699,036 | $-5,112,951 | $-4,355,076 |
| Net Income | $-11,415,372 | $-7,684,226 | $-7,184,365 | $-4,312,288 | $-3,943,920 |
| Net Margin | -300.8% | -151.6% | -173.0% | -3109.0% | -2121.8% |
| EPS | $-0.11 | $-0.11 | $-0.16 | $-0.13 | $-0.23 |
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a multi-cancer panel test for simultaneously screening for various cancers from a single sample of blood with high sensitivity and specificity for each cancer. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; COVID polymerase chain reaction testing and blood test analysis; Prostate Health Index, a screening test for prostate cancer; and BreastSentry, a test to determine a woman's risk for developing breast cancer. The company was founded in 1998 and is headquartered in Richmond Hill, Canada.
Visit WebsiteEarnings History & Surprises
SZLS.TOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 16, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 17, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 28, 2024 | — | — | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 15, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 15, 2023 | — | $-0.03 | — | — |
Q2 2023 | Apr 3, 2023 | — | $-0.23 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.02 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.04 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.04 | — | — |
Q3 2021 | Aug 17, 2021 | — | $0.08 | — | — |
Q2 2021 | May 17, 2021 | — | $-0.14 | — | — |
Q2 2021 | Apr 2, 2021 | — | $0.01 | — | — |
Q4 2020 | Nov 20, 2020 | — | $-0.13 | — | — |
Q3 2020 | Aug 14, 2020 | — | $0.00 | — | — |
Q2 2020 | Jun 1, 2020 | — | $-0.13 | — | — |
Q2 2020 | May 20, 2020 | — | $0.02 | — | — |
Latest News
Frequently Asked Questions about SZLS.TO
What is SZLS.TO's current stock price?
What is the analyst price target for SZLS.TO?
What sector is StageZero Life Sciences Ltd. in?
What is SZLS.TO's market cap?
Does SZLS.TO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SZLS.TO for comparison